Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / BIOTECH ETF
-
Total 13F shares
-
655,117
-
Share change
-
-5,491
-
Total reported value
-
$124,020,656
-
Put/Call ratio
-
302%
-
Price per share
-
$189.26
-
Number of holders
-
111
-
Value change
-
-$596,664
-
Number of buys
-
42
-
Number of sells
-
42
Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q4 2025
As of 31 Dec 2025,
VANECK ETF TRUST - BIOTECH ETF (BBH) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
655,117 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, RAYMOND JAMES FINANCIAL INC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, Miller Investment Management, LP, LPL Financial LLC, WELLS FARGO & COMPANY/MN, UBS Group AG, Bleakley Financial Group, LLC, and Conservest Capital Advisors, Inc..
This page lists
111
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.